Bank Of America Corp Ultragenyx Pharmaceutical Inc. Transaction History
Bank Of America Corp
- $1.12 Trillion
- Q2 2024
A detailed history of Bank Of America Corp transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Bank Of America Corp holds 547,818 shares of RARE stock, worth $27.7 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
547,818
Previous 430,536
27.24%
Holding current value
$27.7 Million
Previous $20.1 Million
12.01%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding RARE
# of Institutions
292Shares Held
88.4MCall Options Held
535KPut Options Held
198K-
Vanguard Group Inc Valley Forge, PA9.78MShares$494 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$283 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA5.35MShares$271 Million0.68% of portfolio
-
Wellington Management Group LLP Boston, MA4.56MShares$230 Million0.03% of portfolio
-
Rtw Investments, LP New York, NY3.26MShares$165 Million2.24% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $3.54B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...